FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892631311> ?p ?o ?g. }

• W2892631311 endingPage "3019" @default.
• W2892631311 startingPage "3011" @default.
• W2892631311 abstract "Compared with the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD), there have been significant changes in the 2017 GOLD classification. The purpose of this study was to analyze the changes in clinical characteristics of the new A-B-C-D system and to explore its role in comprehensive assessment of COPD.A total of 631 stable COPD patients were included in a cross-sectional survey. Data collected included baseline data and pulmonary function testing results, respiratory muscle strength, symptoms and quality of life, exercise capacity, nutritional status, and anxiety and depression as a comprehensive assessment. Based on the 2011 GOLD and 2017 GOLD classifications, patients were divided into Groups A1-D1 and Groups A2-D2, respectively.In the 2011 GOLD, 64 subjects in Group C1 were reclassified into Group A2 (41.6%), while 77 subjects in Group D1 were reclassified into Group B2 (27.1%). The old and new grading systems were somewhat consistent (Cohen's kappa=0.6963, P<0.001). Lung function was lower, while the body mass index, airflow obstruction, dyspnea, and exercise capacity index (BODE index) was higher in Group A2 than in Group A1 (P<0.001). In Group B2, lung function, 6-minute walking distance (6MWD), and respiratory muscle strength were significantly lower than in Group B1 (P<0.001), while the BODE index (P<0.001) was higher. In comprehensive assessment, subjects in Groups B2 and D2 had significantly lower lung function, 6MWD, respiratory muscle strength, quality of life, higher symptom scores, and BODE index than subjects in Group A2 (P<0.001). The differences between Group A2 and C2 were small.Compared with the 2011 GOLD, the 2017 GOLD reclassified more patients into Groups A and B, those with significantly worse lung function and higher BODE index. In the comprehensive assessment of the new classification, Groups B and D may have greater disease severity. However, the effectiveness of the new grading system in predicting patient prognosis, and its guidance on the use of drugs, remains to be explored in future studies." @default.
• W2892631311 created "2018-10-05" @default.
• W2892631311 creator A5006150870 @default.
• W2892631311 creator A5020666476 @default.
• W2892631311 creator A5023128761 @default.
• W2892631311 creator A5039808838 @default.
• W2892631311 creator A5046132791 @default.
• W2892631311 creator A5048170323 @default.
• W2892631311 creator A5061901723 @default.
• W2892631311 creator A5063381428 @default.
• W2892631311 creator A5069544834 @default.
• W2892631311 creator A5081675173 @default.
• W2892631311 date "2018-09-01" @default.
• W2892631311 modified "2023-09-23" @default.
• W2892631311 title "Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China" @default.
• W2892631311 cites W1809582455 @default.
• W2892631311 cites W1859222707 @default.
• W2892631311 cites W1987138256 @default.
• W2892631311 cites W2010967671 @default.
• W2892631311 cites W2019357963 @default.
• W2892631311 cites W2048740227 @default.
• W2892631311 cites W2083436606 @default.
• W2892631311 cites W2097104488 @default.
• W2892631311 cites W2098140855 @default.
• W2892631311 cites W2107829061 @default.
• W2892631311 cites W2108437392 @default.
• W2892631311 cites W2110429964 @default.
• W2892631311 cites W2123023061 @default.
• W2892631311 cites W2127951128 @default.
• W2892631311 cites W2130230386 @default.
• W2892631311 cites W2139347600 @default.
• W2892631311 cites W2144029733 @default.
• W2892631311 cites W2144417097 @default.
• W2892631311 cites W2149849734 @default.
• W2892631311 cites W2157968241 @default.
• W2892631311 cites W2160230146 @default.
• W2892631311 cites W2165095005 @default.
• W2892631311 cites W2583265473 @default.
• W2892631311 cites W2604596332 @default.
• W2892631311 cites W2610342425 @default.
• W2892631311 cites W2752256918 @default.
• W2892631311 cites W2766138818 @default.
• W2892631311 cites W2770883613 @default.
• W2892631311 cites W2782326295 @default.
• W2892631311 cites W4211025614 @default.
• W2892631311 cites W4245666729 @default.
• W2892631311 doi "https://doi.org/10.2147/copd.s174668" @default.
• W2892631311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6167996" @default.
• W2892631311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30319249" @default.
• W2892631311 hasPublicationYear "2018" @default.
• W2892631311 type Work @default.
• W2892631311 sameAs 2892631311 @default.
• W2892631311 citedByCount "8" @default.
• W2892631311 countsByYear W28926313112019 @default.
• W2892631311 countsByYear W28926313112020 @default.
• W2892631311 countsByYear W28926313112021 @default.
• W2892631311 countsByYear W28926313112023 @default.
• W2892631311 crossrefType "journal-article" @default.
• W2892631311 hasAuthorship W2892631311A5006150870 @default.
• W2892631311 hasAuthorship W2892631311A5020666476 @default.
• W2892631311 hasAuthorship W2892631311A5023128761 @default.
• W2892631311 hasAuthorship W2892631311A5039808838 @default.
• W2892631311 hasAuthorship W2892631311A5046132791 @default.
• W2892631311 hasAuthorship W2892631311A5048170323 @default.
• W2892631311 hasAuthorship W2892631311A5061901723 @default.
• W2892631311 hasAuthorship W2892631311A5063381428 @default.
• W2892631311 hasAuthorship W2892631311A5069544834 @default.
• W2892631311 hasAuthorship W2892631311A5081675173 @default.
• W2892631311 hasBestOaLocation W28926313111 @default.
• W2892631311 hasConcept C126322002 @default.
• W2892631311 hasConcept C159110408 @default.
• W2892631311 hasConcept C1862650 @default.
• W2892631311 hasConcept C2776780178 @default.
• W2892631311 hasConcept C2777104659 @default.
• W2892631311 hasConcept C2777168814 @default.
• W2892631311 hasConcept C2779951463 @default.
• W2892631311 hasConcept C2780221984 @default.
• W2892631311 hasConcept C2780779891 @default.
• W2892631311 hasConcept C40993552 @default.
• W2892631311 hasConcept C71924100 @default.
• W2892631311 hasConcept C75603125 @default.
• W2892631311 hasConceptScore W2892631311C126322002 @default.
• W2892631311 hasConceptScore W2892631311C159110408 @default.
• W2892631311 hasConceptScore W2892631311C1862650 @default.
• W2892631311 hasConceptScore W2892631311C2776780178 @default.
• W2892631311 hasConceptScore W2892631311C2777104659 @default.
• W2892631311 hasConceptScore W2892631311C2777168814 @default.
• W2892631311 hasConceptScore W2892631311C2779951463 @default.
• W2892631311 hasConceptScore W2892631311C2780221984 @default.
• W2892631311 hasConceptScore W2892631311C2780779891 @default.
• W2892631311 hasConceptScore W2892631311C40993552 @default.
• W2892631311 hasConceptScore W2892631311C71924100 @default.
• W2892631311 hasConceptScore W2892631311C75603125 @default.
• W2892631311 hasLocation W28926313111 @default.
• W2892631311 hasLocation W28926313112 @default.
• W2892631311 hasLocation W28926313113 @default.
• W2892631311 hasLocation W28926313114 @default.
• W2892631311 hasLocation W28926313115 @default.

• next